Harvard Bioscience, Inc. (HBIO)
7.55
+0.07
(+0.94%)
USD |
NASDAQ |
Aug 24, 16:00
7.34
-0.21
(-2.78%)
After-Hours: 20:00
Harvard Bioscience Shareholders Equity (Quarterly) : 7.418M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.418M |
| March 31, 2026 | 10.05M |
| December 31, 2025 | 13.73M |
| September 30, 2025 | 14.07M |
| June 30, 2025 | 15.73M |
| March 31, 2025 | 14.84M |
| December 31, 2024 | 63.34M |
| September 30, 2024 | 65.32M |
| June 30, 2024 | 67.25M |
| March 31, 2024 | 68.81M |
| December 31, 2023 | 73.07M |
| September 30, 2023 | 74.29M |
| June 30, 2023 | 75.39M |
| March 31, 2023 | 74.34M |
| December 31, 2022 | 72.22M |
| September 30, 2022 | 71.98M |
| June 30, 2022 | 77.50M |
| March 31, 2022 | 76.38M |
| December 31, 2021 | 83.40M |
| September 30, 2021 | 76.89M |
| June 30, 2021 | 78.70M |
| March 31, 2021 | 77.12M |
| December 31, 2020 | 76.68M |
| September 30, 2020 | 77.17M |
| June 30, 2020 | 76.07M |
| Date | Value |
|---|---|
| March 31, 2020 | 76.01M |
| December 31, 2019 | 81.69M |
| September 30, 2019 | 77.10M |
| June 30, 2019 | 80.33M |
| March 31, 2019 | 80.35M |
| December 31, 2018 | 82.72M |
| September 30, 2018 | 80.96M |
| June 30, 2018 | 77.01M |
| March 31, 2018 | 79.29M |
| December 31, 2017 | 80.90M |
| September 30, 2017 | 76.90M |
| June 30, 2017 | 75.21M |
| March 31, 2017 | 72.72M |
| December 31, 2016 | 72.20M |
| September 30, 2016 | 75.89M |
| June 30, 2016 | 76.66M |
| March 31, 2016 | 78.20M |
| December 31, 2015 | 77.60M |
| September 30, 2015 | 94.29M |
| June 30, 2015 | 94.81M |
| March 31, 2015 | 90.50M |
| December 31, 2014 | 95.47M |
| September 30, 2014 | 96.78M |
| June 30, 2014 | 98.23M |
| March 31, 2014 | 96.18M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 7.122B |
| Bio-Rad Laboratories, Inc. | 7.174B |
| Bruker Corp. | 2.381B |
| Danaher Corp. | 52.58B |
| Illumina, Inc. | 2.838B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 76.29M |
| Total Liabilities (Quarterly) | 68.87M |
| Debt to Equity Ratio | 5.959 |
| Current Ratio | 1.874 |
| Net Debt Paydown Yield | 0.29% |